Probing the mechanisms of low immunogenicity of a lipocalin allergen, Bos d 2, in a mouse model

Clinical and Experimental Allergy

Volumn 33, Issue 6, 2003, Pages 834-841

  Immonen, A ^a   Saarelainen, S ^a   Rautiainen, J ^a   Rytkonen Nissinen M ^a   Kinnunen, T ^a   Mantyjarvi R ^a   Virtanen, Tuomas ^a  

^a UNIVERSITY OF EASTERN FINLAND   (Finland)

Author keywords

Allergenicity; Animal allergen; Immune response; Immunogenicity; Lipocalin; T cell

Indexed keywords

ALLERGEN; AMINO ACID DERIVATIVE; ANTIGEN; CANCER GROWTH FACTOR; CARBOXYFLUORESCEIN DIACETATE SUCCINIMIDYL ESTER; CYTOKINE; DYE; INTERLEUKIN 10; INTERLEUKIN 12; INTERLEUKIN 2; INTERLEUKIN 4; LIPOCALIN; LYSOZYME; TETANUS TOXOID;

ALLERGENICITY; ANIMAL CELL; ANIMAL EXPERIMENT; ARTICLE; CELL COUNT; CELL DEATH; CELL LABELING; CELL PROLIFERATION; CELL STIMULATION; CONTROLLED STUDY; CYTOKINE RELEASE; ENZYME LINKED IMMUNOSORBENT ASSAY; FEMALE; HEN; IMMUNIZATION; IMMUNOGENICITY; IN VITRO STUDY; LYMPHOCYTE CULTURE; MOUSE; NONHUMAN; PRIORITY JOURNAL; SPLEEN CELL; T LYMPHOCYTE;

ALLERGENS; ANIMALS; ANTIBODIES; CARRIER PROTEINS; CATTLE; CELL DIVISION; CELLS, CULTURED; CHICK EMBRYO; CYTOKINES; FEMALE; FLOW CYTOMETRY; IMMUNIZATION; INTERLEUKIN-2; INTERLEUKIN-4; MICE; MICE, INBRED BALB C; STIMULATION, CHEMICAL; T-LYMPHOCYTES; TETANUS TOXOID; TRANSFORMING GROWTH FACTOR BETA;

EID: 0037533027     PISSN: 09547894     EISSN: None     Source Type: Journal    
DOI: 10.1046/j.1365-2222.2003.01669.x     Document Type: Article

References (37)

1. Aalberse RC. Structural biology of allergens. J Allergy Clin Immunol 2000; 106:228-38.
2. Zeiler T, Mäntyjärvi R, Rautiaine J et al. T cell epitopes of a lipocalin allergen colocalize with the conserved regions of the molecule. J Immunol 1999; 162:1415-22.
3. Ylönen J, Mäntyjärvi R, Taivainen A, Virtanen T. IgG and IgE antibody responses to cow dander and urine in farmers with cow-induced asthma. Clin Exp Allergy 1992; 22:83-90.
4. Zeiler T, Taivainen A, Mäntyjärvi R et al. Threshold levels of purified natural Bos d 2 for inducing bronchial airway response in asthmatic patients. Clin Exp Allergy 2002; 32:1454-60.
5. Saarelainen S, Zeiler T, Rautiainen J et al. Lipocalin allergen Bos d 2 is a weak immunogen. Int Immunol 2002; 14:401-9.
6. Virtanen T, Zeiler T, Rautiainen J, Mäntyjärvi R. Allergy to lipocalins: a consequence of misguided T-cell recognition of self and nonself? Immunol Today 1999; 20:398-400.
7. Altschul SF, Madden TL, Schaffer AA et al. Gapped BLAST and PSI-BLAST: a new generation of protein database search programs. Nucl Acids Res 1997; 25:3389-402.
8. von Boehmer H. Positive selection of lymphocytes. Cell 1994; 76:219-28.
9. Nossal GJV. Negative selection of lymphocytes. Cell 1994; 76:229-39.
10. + T cells. J Immunol 1996; 157:2160-5.
11. Pfeiffer C, Stein J, Southwood S, Ketelaar H, Sette A, Bottomly K. Altered peptide ligands can control CD4 T lymphocyte differentiation in vivo. J Exp Med 1995; 181:1569-74.
12. Murray JS. How the MHC selects Th1/Th2 immunity. Immunol Today 1998; 19:157-63.
13. + T cells. J Immunol 2002; 168:3825-32.
14. Rautiainen J, Auriola S, Rouvinen J et al. Molecular and crystal properties of Bos d 2, an allergenic protein of the lipocalin family. Bioch Biophys Res Comm 1998; 247:746-50.
15. Rouvinen J, Rautiainen J, Virtanen T et al. Probing the molecular basis of allergy - three-dimensional structure of the bovine lipocalin allergen Bos d 2. J Biol Chem 1999; 274:2337-43.
16. Martin D, Lenardo M. Morphological, biochemical and flow cytometric assays of apoptosis. In: Coico R, ed. Current Protocols in Immunology. Chichester: John Wiley & Sons, 1998:3.17.1-3.17.39.
17. Targoni OS, Lehmann PV. Endogenous myelin basic protein inactivates the high avidity T cell repertoire. J Exp Med 1998; 187:2055-63.
18. Kupfer H, Monks CR, Kupfer A. Small splenic B cells that bind to antigen-specific T helper (Th) cells and face the site of cytokine production in the Th cells selectively proliferate: immunofluorescence microscopic studies of Th-B antigen-presenting cell interactions. J Exp Med 1994; 179:1507-15.
19. Moudgil KD, Sekiguchi D, Kim SY, Sercarz EE. Immunodominance is independent of structural constraints - each region within hen eggwhite lysozyme is potentially available upon processing of native antigen. J Immunol 1997; 159:2574-9.
20. Yip HC, Karulin AY, Tary-Lehmann M et al. Adjuvant-guided type-1 and type-2 immunity: infectious/noninfectious dichotomy defines the class of response. J Immunol 1999; 162:3942-9.
21. + T cell clones mediate the in vivo inhibition of rat IgE. J Immunol 1998; 160:580-7.
22. Schwartz RH. Models of T cell anergy: is there a common molecular mechanism? J Exp Med 1996; 184:1-8.
23. Taams LS, van Eden W, Wauben MHM. Dose-dependent induction of distinct anergic phenotypes: multiple levels of T cell anergy. J Immunol 1999; 162:1974-81.
24. Beverly B, Kang SM, Lenardo MJ, Schwartz RH. Reversal of in vitro T cell clonal anergy by IL-2 stimulation. Int Immunol 1992; 4:661-71.
25. + immunoregulatory T cells suppress polyclonal T cell activation in vitro by inhibiting interleukin 2 production. J Exp Med 1998; 188:287-96.
26. Min B, Legge KL, Pack C, Zaghouani H. Neonatal exposure to a self-peptide-immunoglobulin chimera circumvents the use of adjuvant and confers resistance to autoimmune disease by a novel mechanism involving interleukin 4 lymph node deviation and interferon gamma-mediated splenic anergy. J Exp Med 1998; 188:2007-17.
27. Abbas AK, Murphy KM, Sher A. Functional diversity of helper T lymphocytes. Nature 1996; 383:787-93.
28. Zhai Y, Kupiec-Weglinski JW. What is the role of regulatory T cells in transplantation tolerance? Curr Opin Immunol 1999; 11:497-503.
29. - thymocytes. J Exp Med 1999; 189:279-88.
30. Kurt-Jones EA, Hamberg S, Ohara J, Paul WE, Abbas AK. Heterogeneity of helper/inducer T lymphocytes. I. Lymphokine production and lymphokine responsiveness. J Exp Med 1987; 166:1774-87.
31. Mueller DL, Chiodetti L, Bacon PA, Schwartz RH. Clonal anergy blocks the response to IL-4, as well as the production of IL-2, in dual-producing T helper cell clones. J Immunol 1991; 147:4118-25.
32. + T-cell subset inhibits antigen-specific T-cell responses and prevents colitis. Nature 1997; 389:737-42.
33. + T cells. J Exp Med 1996; 183:2669-74.
34. Wendling U, Paul L, van der Zee R, Prakken B, Singh M, van Eden W. A conserved mycobacterial heat shock protein (HSP) 70 sequence prevents adjuvant arthritis upon nasal administration and induces IL-10-producing T cells that cross-react with the mammalian self-HSP70 homologue. J Immunol 2000; 164:2711-7.
35. Akdis CA, Blaser K. IL-10-induced anergy in peripheral T cell and reactivation by microenvironmental cytokines: two key steps in specific immunotherapy. FASEB J 1999; 13:603-9.
36. + T cells induced by low avidity engagement of T cell receptor. J Exp Med 2001; 194:719-32.
37. Basu D, Williams CB, Allen PM. In vivo antagonism of a T cell response by an endogenously expressed ligand. Proc Natl Acad Sci USA 1998; 95:14332-6.